Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaroslau Compta

Showing results (61-70 of 169) with videos related to

Pageof 17
Sort By:
Parkinsonism & Related Disorders|March 20, 2024
Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work?Kirsys Patricia Del Giudice, Marina Cosgaya, Idoia Zaro, et al.
Brain : a Journal of Neurology|October 28, 2009
Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementiaYaroslau Compta, Joan Santamaria, Luca Ratti, et al.
Journal of the Neurological Sciences|July 18, 2016
White matter hyperintensities, cerebrospinal amyloid-β and dementia in Parkinson's diseaseYaroslau Compta, Mariateresa Buongiorno, Núria Bargalló, et al.
Journal of Clinical Medicine|September 23, 2022
Device for Negative Pressure Wound Therapy in Low-Resource Regions: Open-Source Description and Bench Test EvaluationRamon Farré, Miguel A Rodríguez-Lázaro, Julian Gonzalez-Martin, et al.
Scientific Reports|December 22, 2021
Disrupted functional connectivity in PD with probable RBD and its cognitive correlatesJavier Oltra, Anna Campabadal, Barbara Segura, et al.
Journal of Parkinson'S Disease|April 21, 2020
Olfaction in LRRK2 Linked Parkinson's Disease: Is It Different from Idiopathic Parkinson's Disease?Dolores Vilas, Eduard Tolosa, María Quintana, et al.
Neuroscience Letters|October 19, 2010
High cerebrospinal tau levels are associated with the rs242557 tau gene variant and low cerebrospinal β-amyloid in Parkinson diseaseYaroslau Compta, Mario Ezquerra, Esteban Muñoz, et al.
Movement Disorders Clinical Practice|January 26, 2023
Spastic Paraplegia and Cognitive Impairment Due to a De Novo Pathogenic Variant in <i>Presenilin</i>-1Esteban Muñoz, Meritxell Jodar, Jairo Guerrero, et al.
Frontiers in Aging Neuroscience|September 11, 2023
Altered sleep and neurovascular dysfunction in alpha-synucleinopathies: the perfect storm for glymphatic failureMariateresa Buongiorno, Clara Marzal, Manel Fernandez, et al.
World Neurosurgery|July 5, 2022
Utility of Postoperative Imaging Software for Deep Brain Stimulation Targeting in Patients with Movement DisordersAlmudena Sánchez-Gómez, Paola Camargo, Ana Cámara, et al.
Pageof 17

Showing results (61-70 of 169) with videos related to

Sort By:
Pageof 17
Parkinsonism & Related Disorders|March 20, 2024
Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work?Kirsys Patricia Del Giudice, Marina Cosgaya, Idoia Zaro, et al.
Brain : a Journal of Neurology|October 28, 2009
Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementiaYaroslau Compta, Joan Santamaria, Luca Ratti, et al.
Journal of the Neurological Sciences|July 18, 2016
White matter hyperintensities, cerebrospinal amyloid-β and dementia in Parkinson's diseaseYaroslau Compta, Mariateresa Buongiorno, Núria Bargalló, et al.
Journal of Clinical Medicine|September 23, 2022
Device for Negative Pressure Wound Therapy in Low-Resource Regions: Open-Source Description and Bench Test EvaluationRamon Farré, Miguel A Rodríguez-Lázaro, Julian Gonzalez-Martin, et al.
Scientific Reports|December 22, 2021
Disrupted functional connectivity in PD with probable RBD and its cognitive correlatesJavier Oltra, Anna Campabadal, Barbara Segura, et al.
Journal of Parkinson'S Disease|April 21, 2020
Olfaction in LRRK2 Linked Parkinson's Disease: Is It Different from Idiopathic Parkinson's Disease?Dolores Vilas, Eduard Tolosa, María Quintana, et al.
Neuroscience Letters|October 19, 2010
High cerebrospinal tau levels are associated with the rs242557 tau gene variant and low cerebrospinal β-amyloid in Parkinson diseaseYaroslau Compta, Mario Ezquerra, Esteban Muñoz, et al.
Movement Disorders Clinical Practice|January 26, 2023
Spastic Paraplegia and Cognitive Impairment Due to a De Novo Pathogenic Variant in <i>Presenilin</i>-1Esteban Muñoz, Meritxell Jodar, Jairo Guerrero, et al.
Frontiers in Aging Neuroscience|September 11, 2023
Altered sleep and neurovascular dysfunction in alpha-synucleinopathies: the perfect storm for glymphatic failureMariateresa Buongiorno, Clara Marzal, Manel Fernandez, et al.
World Neurosurgery|July 5, 2022
Utility of Postoperative Imaging Software for Deep Brain Stimulation Targeting in Patients with Movement DisordersAlmudena Sánchez-Gómez, Paola Camargo, Ana Cámara, et al.
Pageof 17